Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

Javier Ariza; Mile Bosilkovski; Antonio Cascio; Juan D Colmenero; Michael J Corbel; Matthew E Falagas; Ziad A Memish; Mohammad Reza Hasanjani Roushan; Ethan Rubinstein; Nikolaos V Sipsas; Javier Solera; Edward J Young; Georgios Pappas

doi:10.1371/journal.pmed.0040317

Loading metrics

Open Access

Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

Javier Ariza,
Mile Bosilkovski,
Antonio Cascio,
Juan D Colmenero,
Michael J Corbel,
Matthew E Falagas,
Ziad A Memish,
Mohammad Reza Hasanjani Roushan,
Ethan Rubinstein,
Nikolaos V Sipsas,
Javier Solera,
Edward J Young,
Georgios Pappas

*To whom correspondence should be addressed. E-mail: gpele@otenet.gr
⨯

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

Javier Ariza,
Mile Bosilkovski,
Antonio Cascio,
Juan D Colmenero,
Michael J Corbel,
Matthew E Falagas,
Ziad A Memish,
Mohammad Reza Hasanjani Roushan,
Ethan Rubinstein,
Nikolaos V Sipsas

Published: December 27, 2007
https://doi.org/10.1371/journal.pmed.0040317

About the Authors

Javier Ariza
Mile Bosilkovski
Antonio Cascio
Juan D Colmenero
Michael J Corbel
Matthew E Falagas
Ziad A Memish
Mohammad Reza Hasanjani Roushan
Ethan Rubinstein
Nikolaos V Sipsas
Javier Solera
Edward J Young
Georgios Pappas: *To whom correspondence should be addressed. E-mail: gpele@otenet.gr

Competing Interests

ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. The other authors have declared that they have no competing interests.

Author Contributions

GP prepared the consequent drafts that were circulated among all other authors for evaluation of intellectual content and revised according to individual suggestions. All authors have seen and approved the final version.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Brucellosis
Is the Subject Area "Brucellosis" applicable to this article?

Thanks for your feedback.
Antibiotics
Is the Subject Area "Antibiotics" applicable to this article?

Thanks for your feedback.
Doxycycline
Is the Subject Area "Doxycycline" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Tetracyclines
Is the Subject Area "Tetracyclines" applicable to this article?

Thanks for your feedback.
Antimicrobials
Is the Subject Area "Antimicrobials" applicable to this article?

Thanks for your feedback.
Streptomycin
Is the Subject Area "Streptomycin" applicable to this article?

Thanks for your feedback.
Brucella
Is the Subject Area "Brucella" applicable to this article?

Thanks for your feedback.